Alnylam Pharmaceuticals





Ebit Cambiamento Data
Acadia Pharmaceuticals USD 35.76M 3.38M 2025-09
Agios Pharmaceuticals USD -121.58M 4.71M 2025-12
Alnylam Pharmaceuticals USD 29.4M 59.36M 2025-12
Amgen USD 3.96B 464M 2025-12
Arrowhead Research USD 40.81M 17.01M 2025-12
BioCryst Pharmaceuticals USD -4.51M 12.2M 2024-12
BioMarin Pharmaceutical USD 198.39M 230.08M 2025-12
Incyte USD 383.88M 47.44M 2025-12
Ionis Pharmaceuticals USD -160.18M 304.96M 2025-09
Moderna USD -857M 597M 2025-12
Neurocrine Biosciences USD 227.9M 11.4M 2025-12
Novartis USD 4.48B 343M 2025-09
PTC Therapeutics USD -81.62M 85.11M 2025-12
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Sanofi EUR 3.74B 2.23B 2025-09
Sarepta Therapeutics USD -62.88M 178.46M 2025-09
Takeda JPY 257.49B 568.56B 2025-12
Tectonic Therapeutic USD -22.33M 4.03M 2025-06
Ultragenyx Pharmaceutical USD -114M 56.89M 2025-12
Vertex Pharmaceuticals USD 1.26B 24.5M 2025-12
Xencor USD -47.52M 24.69M 2025-09


Alnylam Pharmaceuticals - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.